Post date
25/06/2025
VIVES Partners’ portfolio investment The Akkermansia Company (TAC) acquired by Danone
Acquisition of TAC’s gut microbiota product, with benefits for people at risk of cardiovascular disease
Post date
14/02/2025
At 12 months, 100% of participants with distal radius fractures treated in trial with NVDX3, an allogenic stem-cell derived bone graft material, demonstrated durable bone union
No adverse events
Post date
14/02/2025
BiocSol succeeds in its ambition to raise a total of €10M since inception to fast-track the development of its sustainable crop protection solutions - testament to the sector’s growing interest in its
Post date
17/12/2024
Eligo welcomes genetic medicines leader Bobby Gaspar as chair of its board of directors
Oct 1, 2024
-
Dr. Gaspar brings invaluable expertise to gene-editing pioneering company Eligo as it prepares
Post date
17/12/2024
Generare raises €5m to scale the discovery of new medicines and molecules hiding in microbes
- Generare uses a novel cloning technique to break down microbial DNA and accelerate the discovery of
Post date
20/11/2024
BiocSol secures €5.2M seed funding to transform sustainable crop protection with next generation microbial-based solutions, targeting total €10M in funding by year-end
- Built on decade of research
Post date
18/11/2024
ATB Therapeutics Raises €54 Million Series A Financing to Propel Innovative Antibody Payload Technology into Clinical Development
• Financing co-led by EQT Life Sciences and MRL Ventures Fund (MRLV
Post date
13/09/2024
- New investment from Luxembourg Future Fund 2 brings total funding to €75M, well above original target
- Deal underlines VIVES’ know-how in connecting academic research and innovative projects with
Post date
10/09/2024
Funding will go towards development of first long-term percutaneous right ventricular assist device
Paris, France, September 10, 2024 – Brightflow SAS, a privately held pioneer in the field of long
Post date
31/01/2024
- European Investment Fund instrumental in success of second closing
- With €38M increased funding capacity, VIVES IUF set to create ten new science-based ventures and support ten current portfolio
Post date
20/09/2023
LMO (Luxembourg & UK) and In-Space Missions Ltd (UK) have partnered to explore the use of small satellite platforms for space-based Space Domain Awareness (SDA) as part of LMO’s AUREA (Autonomous
Post date
11/07/2023
New funding will support the rapid growth of Aphea.Bio, solidifying its position as a frontrunner in biological product development for agriculture.
Gent, Belgium, 11 July 2023 – Aphea.Bio, a Belgium